My watch list
my.chemeurope.com  
Login  

02-28-2007: ChemDiv, Inc. and Kaken Pharmaceutical Co., Ltd. of Tokyo, Japan have announced that they entered into a joint Drug Discovery collaboration involving undisclosed therapeutic targets.

ChemDiv is to produce lead candidates employing its Discovery Outsource TM platform, including proprietary rational design, extensive medicinal chemistry and pre-clinical biology capabilities. The designed chemical libraries will be screened at ChemDiv on Kaken's drug targets with subsequent lead optimization effort.

Watchlist

This is where you can add this news to your personal favourites

Facts, background information, dossiers
More about ChemDiv
Most read news
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE